Plant Comparison
Pygeum vs Goldenrod
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Pygeum and Goldenrod: they share 5 indicated uses (arthritis / joint pain, inflammation (general), skin irritation, …); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Pygeum | Goldenrod | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Pygeum |
| Inflammation (general) | 2/10 | 2/10 | Comparable evidence |
| Skin irritation | 5/10 | 1/10 | Stronger for Pygeum |
| Urinary support | 10/10 | 7/10 | Stronger for Pygeum |
| Urinary tract infection (UTI) | 9/10 | 2/10 | Stronger for Pygeum |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
Safety, Cautions & Contraindications
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer. The evidence is mixed and rests on small, short, methodologically weak trials, so men with moderate or severe BPH should not rely on it instead of proven treatment.
Generally well tolerated, with mild gastrointestinal effects the most common report.
Generally well tolerated. Not recommended in cases of fluid retention due to impaired cardiac or renal function. Ensure adequate fluid intake when using as a diuretic. May cause allergic reactions in individuals sensitive to Asteraceae plants. Avoid use during pregnancy and breastfeeding due to limited safety data.
Duke (2002) provides clinical evidence (score 2) for goldenrod's anti-inflammatory activity, consistent with Commission E approval. It is also classified as an aquaretic (increases urine output without electrolyte loss) and antispasmodic, used for urinary tract irrigation therapy. Dose: 6–12 g dried herb daily as tea for urinary complaints. Duke cautions against use in cases of edema from renal or cardiac insufficiency, and notes that the herb may cause allergic reactions in individuals sensitive to Asteraceae plants (Duke, 2002).
External Ids
Botanical Description
Evergreen tree (Rosaceae), 10-30 m tall, with dark, fissured, red-brown bark (the source of the common name 'red stinkwood', from its unpleasant smell when cut). Leaves are glossy dark green, leathery, oblong with finely toothed margins. Small white, five-petalled flowers are borne in axillary racemes, followed by small reddish-brown, two-lobed fruit.
Perennial herb (Asteraceae), 20-100 cm tall, with erect, often reddish, downy or smooth stems. Leaves are alternate, lance-shaped and toothed. Numerous small, bright yellow, daisy-like flower heads are clustered into branched, plume-like terminal sprays, followed by small ribbed achenes with a tuft of hairs (pappus).[1]
Habitat
Native to montane forests of central and southern Africa (and Madagascar), growing at moderate to high altitude (roughly 900-3400 m). The species is CITES-listed and conservation-threatened owing to over-harvesting of bark for the pharmaceutical trade.
Harvesting
Bark is traditionally stripped from mature trees. Unsustainable stripping - especially removing bark all the way round the trunk - kills the tree and has driven population decline, so sustainable, partial and rotational bark harvesting or cultivated sources are recommended.
The flowering aerial parts are cut during flowering (late summer) and dried.[11]
Traditional Uses
Prunus africana bark has a traditional use in East and Central African ethnomedicine for urinary complaints, and its extract (marketed as Pygeum) became one of the most widely used European phytotherapy remedies for benign prostatic hyperplasia (BPH) symptoms in the 20th century. Clinical evidence for symptom benefit is moderate but drawn from small, methodologically weak trials.[11]
Goldenrod has a long European folk-medicine tradition as a mild 'aquaretic' diuretic and anti-inflammatory remedy for the urinary tract, used traditionally for urinary-tract irrigation therapy alongside adequate fluid intake, and topically as a wound herb (one common name is 'woundwort'). Modern phytochemical work confirms saponin- and flavonoid-driven anti-inflammatory, antioxidant and diuretic activity.[1, 11]
Preparations
Dosage
Clinical trials have most often used around 100-200 mg/day of standardised lipophilic bark extract, divided into two doses. Educational reference only, not a prescription; any prostate or urinary symptom should be medically assessed first.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Thompson, R.Q., Katz, D. and Sheehan, B (2019) 'Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health', Journal of Pharmaceutical and Biomedical Analysis, 163, pp. 162-169. doi:10.1016/j.jpba.2018.10.004 Preclinical
https://doi.org/10.1016/j.jpba.2018.10.004 - Dvorkin, L. and Song, K.Y (2002) 'Herbs for benign prostatic hyperplasia', The Annals of Pharmacotherapy, 36(9), pp. 1443-1452. doi:10.1345/aph.1A228 Meta-analysis / review
https://doi.org/10.1345/aph.1A228 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology, 22(Suppl 1), pp. 18-23. Meta-analysis / review
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Kim, T.H., Lim, H.J., Kim, M.S. and Lee, M.S (2012) 'Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews', Maturitas, 73(3), pp. 180-185. doi:10.1016/j.maturitas.2012.07.007 Meta-analysis / review
https://doi.org/10.1016/j.maturitas.2012.07.007 - Cambronero, J., Osca-Garcia, J.M., Merino-Salas, S., Miguel, J.M. and others (2022) 'Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)', Archivos Espanoles de Urologia, 75(3), pp. 219-227. Clinical study
https://scholar.google.com/scholar?q=Effectiveness%20of%20treatment%20with%20Pygeum%20africanum%20in%20patients%20with%20lower%20urinary%20tract%20symptoms%20and%20benign%20prostatic%20hyperplasia%3A%20a%20cross-sectional%20study%20in%20the%20real-world%20clinical%20practice%20in%20Spain%20%28The%20PROFIT%20Study%29 - Quiles, M.T., Arbos, M.A., Fraga, A., de Torres, I.M. and others (2010) 'Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)', The Prostate, 70(10), pp. 1044-1053. doi:10.1002/pros.21138 Preclinical
https://doi.org/10.1002/pros.21138 - Salinas-Casado, J., Esteban-Fuertes, M., Carballido-Rodriguez, J. and Cozar-Olmo, J.M (2020) 'Review of the experience and evidence of Pygeum africanum in urological practice', Actas Urologicas Espanolas, 44(1), pp. 9-13. doi:10.1016/j.acuro.2019.08.002 Meta-analysis / review
https://doi.org/10.1016/j.acuro.2019.08.002 - Villar, A., Silva-Fuentes, F., Mula, A. and Zangara, A (2024) 'Anti-Inflammatory Potential of Prunus africana Bark Extract: An In Vitro Study of Cytokine Release by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells', International Journal of Molecular Sciences, 25(15), pp. 8298. doi:10.3390/ijms25158298 Preclinical
https://doi.org/10.3390/ijms25158298 - Larre, S., Camparo, P., Comperat, E., Boulbes, D. and others (2012) 'Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures', Asian Journal of Andrology, 14(3), pp. 499-504. doi:10.1038/aja.2011.132 Preclinical
https://doi.org/10.1038/aja.2011.132 - Rubegeta, E., Makolo, F., Kamatou, G., Enslin, G. and others (2023) 'The African cherry: A review of the botany, traditional uses, phytochemistry, and biological activities of Prunus africana (Hook.f.) Kalkman', Journal of Ethnopharmacology, 305, pp. 116004. doi:10.1016/j.jep.2022.116004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2022.116004 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology. Randomized trial
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Dedhia, R.C. and McVary, K.T (2008) 'Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia', The Journal of Urology, 179(6), pp. 2119--2125. doi:10.1016/j.juro.2008.01.094 Meta-analysis / review
https://doi.org/10.1016/j.juro.2008.01.094 - Wilt, T. and Ishani, A. and Mac Donald, R. and Rutks, I. and Stark, G (2002) 'Pygeum africanum for benign prostatic hyperplasia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001044 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001044
- Fursenco, C., Calalb, T., Uncu, L., Dinu, M. and others (2020) 'Solidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities', Biomolecules, 10(12), pp. 1619. doi:10.3390/biom10121619 Meta-analysis / review
https://doi.org/10.3390/biom10121619 - Abdel Motaal, A., Ezzat, S.M., Tadros, M.G. and El-Askary, H.I (2016) 'In vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats', Pharmaceutical Biology, 54(12), pp. 2864-2870. doi:10.1080/13880209.2016.1190381 Preclinical
https://doi.org/10.1080/13880209.2016.1190381 - Précheur, I., Rolland, Y., Hasseine, L., Orange, F. and others (2020) 'Solidago virgaurea L. Plant Extract Targeted Against Candida albicans to Reduce Oral Microbial Biomass: A Double Blind Randomized Trial on Healthy Adults', Antibiotics, 9(4), pp. 137. doi:10.3390/antibiotics9040137 Randomized trial
https://doi.org/10.3390/antibiotics9040137 - Wojnicz, D., Tichaczek-Goska, D., Glensk, M. and Hendrich, A.B (2021) 'Is It Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli Rods? An In Vitro Model Study', Pharmaceutics, 13(4), pp. 573. doi:10.3390/pharmaceutics13040573 Preclinical
https://doi.org/10.3390/pharmaceutics13040573 - El-Tantawy, W.H (2013) 'Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity', Journal of Physiology and Biochemistry, 70(1), pp. 33-42. doi:10.1007/s13105-013-0277-0 Preclinical
https://doi.org/10.1007/s13105-013-0277-0 - Gross, S.C., Goodarzi, G., Watabe, M., Bandyopadhyay, S. and others (2002) 'Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model', Nutrition and Cancer, 43(1), pp. 76-81. doi:10.1207/S15327914NC431_9 Preclinical
https://doi.org/10.1207/S15327914NC431_9 - Starks, C.M., Williams, R.B., Goering, M.G., O'Neil-Johnson, M. and others (2010) 'Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea)', Phytochemistry, 71(1), pp. 104-109. doi:10.1016/j.phytochem.2009.09.032 Preclinical
https://doi.org/10.1016/j.phytochem.2009.09.032 - Malicanin, M., Karabegovic, I., Dordevic, N., Mancic, S. and others (2024) 'Influence of the Extraction Method on the Biological Potential of Solidago virgaurea L. Essential Oil and Hydrolates', Plants, 13(16), pp. 2187. doi:10.3390/plants13162187 Preclinical
https://doi.org/10.3390/plants13162187 - Zehra, S.A., Bhattarai, P., Zhang, J., Liu, Y. and others (2022) 'Phytochemical Analysis and Evaluation of the Antidiabetic Activity of Solidago virgaurea Extracts', Current Bioactive Compounds, 19(4), pp. e150622206146. doi:10.2174/1573407218666220615143502 Preclinical
https://doi.org/10.2174/1573407218666220615143502 - Jang, Y.S., Wang, Z., Lee, J.M., Lee, J.Y. and others (2016) 'Screening of Korean Natural Products for Anti-Adipogenesis Properties and Isolation of Kaempferol-3-O-rutinoside as a Potent Anti-Adipogenetic Compound from Solidago virgaurea', Molecules, 21(2), pp. 226. doi:10.3390/molecules21020226 Preclinical
https://doi.org/10.3390/molecules21020226 - European Medicines Agency (2008) 'Community herbal monograph on Solidago virgaurea L., herba'. Traditional / reference
https://scholar.google.com/scholar?q=Community%20herbal%20monograph%20on%20Solidago%20virgaurea%20L.%2C%20herba - Bader, G., Binder, K., Hiller, K. and Zwintscher, U (1990) 'The saponins from Solidago virgaurea L', 45(8), pp. 618--622. Traditional / reference
https://scholar.google.com/scholar?q=The%20saponins%20from%20Solidago%20virgaurea%20L - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Grow Forage Cook Ferment 'Foraging Goldenrod (Solidago): Identification and Uses'. Available at: https://www.growforagecookferment.com/foraging-goldenrod/ Traditional / reference
https://www.growforagecookferment.com/foraging-goldenrod/ - Washington State Noxious Weed Control Board 'Tansy Ragwort (Senecio jacobaea)'. Available at: https://www.nwcb.wa.gov/weeds/tansy-ragwort Traditional / reference
https://www.nwcb.wa.gov/weeds/tansy-ragwort - Schneider, J. and Tsegaye, Y. and W/Tensae, M. and G/Selassie, S. and Haile, T. and Bane, A. and Ali, A. and Mesfin, G. and Seboxa, T (2012) 'Veno-occlusive liver disease: a case report', Ethiopian Medical Journal, 50 Suppl 2, pp. 47-51. Available at: https://pubmed.ncbi.nlm.nih.gov/22946295/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22946295/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.